Clinical Trial Update: An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease [Phase 3]

View source ↗

Summary

An open-label Phase 3 extension trial assessed the long-term safety of rotigotine in advanced Parkinson's disease. The study has completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Rotigotine (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-12-18